“…Erythromycin and lincomycin have been compared in several previous studies, with the conclusion, usually, that erythromycin is slightly more active and is thus the more useful drug, except possibly in the treatment of osteomyelitis, for which lincomycin is preferred, but on the basis of pharmacological rather than microbiological properties (Barber and Waterworth, 1964;Geddes, Sleet, and Murdoch, 1964;Mc-Millan, McRae, and McDougall, 1967;Sanders, 1969).…”